EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disruption of HSD17B12 in mouse hepatocytes leads to reduced body weight and defect in the lipid droplet expansion associated with microvesicular steatosis

Hanna Heikelä iD, Laura Mairinoja iD, Suvi T Ruohonen iD, Kalle T Rytkönen iD, Simone de Brot iD, Asta Laiho iD, Satu Koskinen iD, Tomi Suomi iD, Laura L Elo iD, Leena Strauss iD, Matti Poutanen iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202400333rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Hanna Heikelä und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Integrative Physiology and Pharmacology and Turku Center for Disease Modeling, Institute of Biomedicine, University of Turku, Tur…. Hauptthemen laut MEDLINE: Lipid Droplets, Hepatocytes, Fatty Liver, Mice, Knockout. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sigrid Juséliuksen Säätiö (Sigrid Jusélius Stiftelse), UTU | Institute of Biomedicine, University of Turku (Biolääketieteen laitos), Jalmari ja Rauha Ahokkaan Säätiö (Jalmari and Rauha Ahokas Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The function of hydroxysteroid dehydrogenase 12 (HSD17B12) in lipid metabolism is poorly understood. To study this further, we created mice with hepatocyte‐specific knockout of HSD17B12 (LiB12cKO). From 2 months on, these mice showed significant fat accumulation in their liver. As they aged, they also had a reduced whole‐body fat percentage. Interestingly, the liver fat accumulation did not result in the typical formation of large lipid droplets (LD); instead, small droplets were more prevalent. Thus, LiB12KO liver did not show increased macrovesicular steatosis with the increasing fat content, while microvesicular steatosis was the predominant feature in the liver. This indicates a failure in the LD expansion. This was associated with liver damage, presumably due to lipotoxicity. Notably, the lipidomics data did not support an essential role of HSD17B12 in fatty acid (FA) elongation. However, we did observe a decrease in the quantity of specific lipid species that contain FAs with carbon chain lengths of 18 and 20 atoms, including oleic acid. Of these, phosphatidylcholine and phosphatidylethanolamine have been shown to play a key role in LD formation, and a limited amount of these lipids could be part of the mechanism leading to the dysfunction in LD expansion. The increase in the Cidec expression further supported the deficiency in LD expansion in the LiB12cKO liver. This protein is crucial for the fusion and growth of LDs, along with the downregulation of several members of the major urinary protein family of proteins, which have recently been shown to be altered during endoplasmic reticulum stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid DropletsHepatocytesFatty LiverMice, KnockoutAnimalsMice17-Hydroxysteroid DehydrogenasesLipid MetabolismBody WeightLiverMaleMice, Inbred C57BLFatty Acids

Stichwörter der Autor:innen

17‐hydroxysteroid dehydrogenasescomputer assisted image analysislipid dropletsliver steatosisnonalcoholic fatty liver disease

Substanzen

17-Hydroxysteroid DehydrogenasesFatty Acids

Autor:innen und Institutionen

  • Research Centre for Integrative Physiology and Pharmacology and Turku Center for Disease Modeling, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • COMPATH, Institute of Animal Pathology, University of Bern, Bern, Switzerland.
  • Department of Internal Medicine and Clinical Nutrition, Centre for Bone and Arthritis Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Hanna Heikelä, Laura Mairinoja, Suvi T Ruohonen, Kalle T Rytkönen, Simone de Brot, Asta Laiho, Satu Koskinen, Tomi Suomi, Laura L Elo, Leena Strauss, Matti Poutanen

Förderung

  • Sigrid Juséliuksen Säätiö (Sigrid Jusélius Stiftelse)
  • UTU | Institute of Biomedicine, University of Turku (Biolääketieteen laitos)
  • Jalmari ja Rauha Ahokkaan Säätiö (Jalmari and Rauha Ahokas Foundation)
  • Institute of Biomedicine, University of Turku

Zitieren

APA

Heikelä, H., Mairinoja, L., Ruohonen, S. T., Rytkönen, K. T., de Brot, S., Laiho, A., Koskinen, S., Suomi, T., Elo, L. L., Strauss, L., & Poutanen, M. (2024). Disruption of HSD17B12 in mouse hepatocytes leads to reduced body weight and defect in the lipid droplet expansion associated with microvesicular steatosis. The FASEB Journal. https://doi.org/10.1096/fj.202400333rr

Vancouver

Heikelä H, Mairinoja L, Ruohonen ST, Rytkönen KT, de Brot S, Laiho A, et al. Disruption of HSD17B12 in mouse hepatocytes leads to reduced body weight and defect in the lipid droplet expansion associated with microvesicular steatosis. The FASEB Journal. 2024. doi:10.1096/fj.202400333rr

BibTeX
@article{Heikel2024,
  author = {Heikelä, Hanna and Mairinoja, Laura and Ruohonen, Suvi T and Rytkönen, Kalle T and de Brot, Simone and Laiho, Asta and Koskinen, Satu and Suomi, Tomi and Elo, Laura L and Strauss, Leena and Poutanen, Matti},
  title = {Disruption of HSD17B12 in mouse hepatocytes leads to reduced body weight and defect in the lipid droplet expansion associated with microvesicular steatosis},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202400333rr}
}
Kostenlos starten →